Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Barbet J, Campion L, Kraeber-Bodere F, Chatal JF, GTE Study Group (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084
2. Bartsch DK, Luster M, Buhr HJ, Lorenz D, Germer CT, Goretzki PE, German Society for General and Visceral Surgery (2018) Indications for the surgical management of benign goiter in adults. Dtsch Arztebl Int 115:1–7
3. Brandenburg T, Führer D (2020) Systemtherapien bei metastasierten Schilddrüsenkarzinomen – zugelassene Therapien und neue Ansätze. Chirurg 91(12):1038–1043
4. Castroneves LA, Coura Filho G, de Freitas RMC, Salles R, Moyses RA, Lopez RVM, Pereira MAA, Tavares MR, Jorge AAL, Buchpiguel CA, Hoff AO (2018) Comparison of 68Ga PET/CT to other imaging studies in medullary thyroid cancer: superiority in detecting bone metastases. J Clin Endocrinol Metab 103:3250–3259
5. Costante G, Meringolo D (2020) Calcitonin as a biomarker of C cell disease: recent achievements and current challenges. Endocrine 67:273–280